Metraipolis › archive › dc_ecde4b2e0748

NRF2 immunobiology in cancer: implications for immunotherapy and therapeutic targeting — Europe PMC PMID:40946102

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40946102
DOI
10.1038/s41388-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-09T23:36:06.537Z
SHA-256 of the archived text
8ed1ec0bbf8975256d5b2162d0b5dca61ae1854254294fed8155e8105e2a4013
Stable URL of this page
https://metraipolis.com/documento/dc_ecde4b2e0748

How to cite

NRF2 immunobiology in cancer: implications for immunotherapy and therapeutic targeting — Europe PMC PMID:40946102 — Europe PMC (en), https://europepmc.org/article/MED/40946102 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ecde4b2e0748 (Metraipolis archive dc_ecde4b2e0748, sha256 8ed1ec0bbf8975256d5b2162d0b5dca61ae1854254294fed8155e8105e2a4013)
BibTeX
@misc{dcecde4b2e0748,
  title = {NRF2 immunobiology in cancer: implications for immunotherapy and therapeutic targeting — Europe PMC PMID:40946102},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40946102},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ecde4b2e0748; sha256 8ed1ec0bbf8975256d5b2162d0b5dca61ae1854254294fed8155e8105e2a4013},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40946102. Agents can read the archived copy with the MCP tool read_document.